Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Guselkumab (an IL-23–specific mAb) demonstrates clinical and molecular response in patients with moderate-to-severe psoriasis

PaperCitations, authors & open-access status

Guselkumab (an IL-23–specific mAb) demonstrates clinical and molecular response in patients with moderate-to-severe psoriasis is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 315 citations, 2014 year and hybrid oa status.

315
Citations
2014
Year
hybrid
OA Status

Related on ScholarIQ

Philippe Szapary
Author
Journal of Allergy and Clinical Immunology
Journal
Psoriasis: Treatment and Pathogenesis
Topic
Psoriasis: Treatment and Pathogenesis
Topic
Spondyloarthritis Studies and Treatments
Topic
Dermatology and Skin Diseases
Topic
470M+ articles · free account